Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nana Dwumfour
Observed name:
Dwumfour, Nana
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0003-0411-6123
Observed ORCID:
0009-0003-0411-6123
OpenAlex ID:
A5007153148
Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic
2023
·
Sara Karami
, Cooma Asonye
, et al.
·
Clinical Toxicology
·
12
PDF
Adverse Reactions Identified after Approval of Novel Medicines: Analysis of 339 New Molecular Entities and Therapeutic Biologics
2026
·
Ellen Pinnow
, Brendan Day
, et al.
·
Clinical Pharmacology & Therapeutics
·
1
Adult U.S. Poison Center Exposure Case Trends Involving Nonprescription Dextromethorphan Amid the COVID-19 Pandemic: a Quasi-experimental Interrupted Time Series Study
2026
·
Sara Karami
, Christian Angelo I. Ventura
, et al.
·
Journal of Medical Toxicology
Show more works
View as search
Works count:
4
Citation count:
13
H-index:
1
I10-index:
1
Year
Topic
Type